Advertisement
Screener

PDL BioPharma, Inc. Assets, Fair Value Disclosure

PDL BioPharma, Inc. Assets, Fair Value Disclosure

PDL BioPharma, Inc. had Assets, Fair Value Disclosure of $321.59 million as of 2020-06-30, per its 10-Q filed 2020-08-07.

Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)

us-gaap:AssetsFairValueDisclosure · last filed 2021-03-29

  • 2020-06-30: Assets, Fair Value Disclosure $321.59M.
  • 2020-03-31: Assets, Fair Value Disclosure $426.46M.
  • 2019-12-31: Assets, Fair Value Disclosure $493.88M.
  • 2019-09-30: Assets, Fair Value Disclosure $622.30M.
Period endAssets, Fair Value DisclosureAssets, Fair Value Disclosure as first filed
2020-06-30$321.59M
10-Q · filed 2020-08-07
2020-03-31$426.46M
10-Q · filed 2020-05-11
2019-12-31$493.88M
10-K · filed 2021-03-29
2019-09-30$622.30M
10-Q · filed 2019-11-06
2019-06-30$650.14M
10-Q · filed 2019-08-07
2019-03-31$603.79M
10-Q · filed 2019-05-09
2018-12-31$603.29M
8-K · filed 2020-06-29
2018-09-30$603.95M
10-Q · filed 2018-11-07
2018-06-30$659.37M
10-Q · filed 2018-08-09
2018-03-31$664.58M
10-Q · filed 2018-05-09
2017-12-31$771.66M
10-K · filed 2019-03-15
2017-09-30$373.13M
10-Q · filed 2017-11-13
2017-06-30$438.25M
10-Q · filed 2017-08-03
2017-03-31$389.01M
10-Q · filed 2017-05-03
2016-12-31$497.39M
10-K · filed 2018-03-16
2016-09-30$494.04M
10-Q · filed 2016-11-03
2016-06-30$475.00M
10-Q · filed 2016-08-04
2016-03-31$556.83M
10-Q · filed 2016-05-04
2015-12-31$499.26M
10-K · filed 2017-03-01
2015-09-30$532.10M
10-Q · filed 2015-11-04
2015-06-30$427.45M
10-Q · filed 2015-08-05
2015-03-31$474.42M
10-Q · filed 2015-05-06
2014-12-31$487.42M
10-K · filed 2016-02-23
2014-09-30$418.89M
10-Q · filed 2014-11-10
2014-06-30$405.47M
10-Q · filed 2014-08-18
2014-03-31$168.61M
10-Q · filed 2014-05-12
2013-12-31$326.88M
10-K · filed 2015-02-23
$91.21M
10-K · filed 2014-03-03
2013-09-30$276.67M
10-Q · filed 2013-11-06
2013-06-30$267.63M
10-Q · filed 2013-08-08
2012-12-31$160.79M
10-K · filed 2014-03-03
2011-09-30$230.87M
10-Q · filed 2011-11-09
2011-06-30$245.81M
10-Q · filed 2011-07-29
2010-12-31$260.24M
10-Q · filed 2011-11-09